Ropinirole PR ( DrugBank: Ropinirole )

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	21

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-002827-17-SK (EUCTR)	17/09/2013	04/03/2013	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 15.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: Local Trade Name, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Prop ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
2	EUCTR2011-002827-17-EE (EUCTR)	23/04/2013	08/02/2013	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: REQUIP-MODUTAB , 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propo ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
3	EUCTR2011-002828-41-EE (EUCTR)	23/04/2013	08/02/2013	A study to test the effectiveness of varying doses of ropinirole PRwhile taking L-dopa in patients w ...	A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L- ...	Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propos ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Taiwan;Estonia;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
4	EUCTR2011-002828-41-SK (EUCTR)	27/03/2013	04/03/2013	A study to test the effectiveness of varying doses of ropinirole PRwhile taking L-dopa in patients w ...	A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L- ...	Advanced Parkinson's disease. MedDRA version: 16.0;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: Requip Modutab, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propos ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Estonia;Taiwan;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
5	NCT01494532 (ClinicalTrials.gov)	April 2, 2012	1/12/2011	A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced ...	A Fixed Dose, Dose-response Study of Ropinirole Prolonged Release (PR) as Adjunctive Treatment to L- ...	Parkinson Disease	Drug: ropinirole/L-dopa;Drug: placebo/L-dopa	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	352	Phase 4	United States;Argentina;Chile;Estonia;Korea, Republic of;Russian Federation;Slovakia;Poland
6	NCT01485172 (ClinicalTrials.gov)	January 31, 2012	1/12/2011	A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Park ...	A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release (PR) in Patients With Early Stage ...	Parkinson Disease	Drug: ropinirole monotherapy;Drug: placebo monotherapy	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	186	Phase 4	United States;Estonia;Korea, Republic of;Russian Federation;Slovakia;Poland
7	NCT01435915 (ClinicalTrials.gov)	June 28, 2010	1/9/2011	Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects	A Single Dose and Repeat Dose Study to Investigate the Pharmacokinetics of Ropinirole After Single a ...	Parkinson Disease	Drug: Ropinirole	GlaxoSmithKline	NULL	Completed	18 Years	45 Years	All	24	Phase 1	China
8	NCT01154166 (ClinicalTrials.gov)	February 15, 2010	29/6/2010	A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatm ...	A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatm ...	Parkinson Disease	Drug: ReQuip PR;Drug: Placebo	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	347	Phase 3	China
9	NCT01371682 (ClinicalTrials.gov)	September 18, 2009	10/6/2010	A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Rel ...	An Open Label Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole P ...	Parkinson Disease	Drug: Ropinirole XL	GlaxoSmithKline	NULL	Completed	18 Years	50 Years	All	50	Phase 1	Belgium
10	NCT00986245 (ClinicalTrials.gov)	September 2009	24/9/2009	Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily	An Open-label, Multi-center, Crossover Study to Compare the Effect of Once-daily Ropinirole PRand Tw ...	Parkinson Disease	Drug: Ropinirole Prolonged release	Seoul National University Hospital	NULL	Completed	30 Years	80 Years	All	82	Phase 4	Korea, Republic of

First Previous1 2 3Next Last